1200 例患者项目：创建一个新的医学模型系统，用于临床实施药物基因组学。
The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics.
机构信息
Department of Medicine, The University of Chicago, Chicago, Illinois, USA.
出版信息
Clin Pharmacol Ther. 2012 Oct;92(4):446-9. doi: 10.1038/clpt.2012.117. Epub 2012 Aug 29.
Abstract
The paradigm of individualized drug therapy based on genetics is an ideal that is now potentially possible. However, translation of pharmacogenomics into practice has encountered barriers such as limited availability and the high cost of genetic testing, the delays involved, disagreements about interpretation of results, and even lack of understanding about pharmacogenomics in general. We describe our institutional pharmacogenomics-implementation project, "The 1200 Patients Project," a model designed to overcome these barriers and facilitate the availability of pharmacogenomic information for personalized prescribing.
摘要
基于遗传学的个体化药物治疗模式是一种理想，现在已经具有实现的可能性。然而，药物基因组学向实践的转化遇到了一些障碍，如遗传检测的可及性有限且费用高昂、检测过程耗时、对结果的解读存在分歧，甚至对药物基因组学缺乏了解等。我们介绍了本机构的药物基因组学实施项目，即“1200 名患者项目”，该模型旨在克服这些障碍，为个体化用药提供药物基因组学信息。
相似文献
1
The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics.1200 例患者项目：创建一个新的医学模型系统，用于临床实施药物基因组学。
Clin Pharmacol Ther. 2012 Oct;92(4):446-9. doi: 10.1038/clpt.2012.117. Epub 2012 Aug 29.
2
Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care.改善治疗历程：治疗前药物基因组学在患者护理中的效用
Clin Pharmacol Ther. 2017 Jan;101(1):39-41. doi: 10.1002/cpt.543. Epub 2016 Nov 21.
3
Pharmacogenomics and individualized medicine: translating science into practice.药物基因组学与个体化医学：将科学转化为实践。
Clin Pharmacol Ther. 2012 Oct;92(4):467-75. doi: 10.1038/clpt.2012.120. Epub 2012 Sep 5.
4
PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.PACE 向前推进——使药物基因组学检测具有现实临床实用性。
Clin Pharmacol Ther. 2019 Jan;105(1):42-44. doi: 10.1002/cpt.1274. Epub 2018 Dec 5.
5
Implementation of pharmacogenomics in product information.药物基因组学在产品信息中的应用。
Pharmacogenomics. 2020 May;21(7):443-448. doi: 10.2217/pgs-2019-0166. Epub 2020 Apr 27.
6
From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions.从人类遗传学和基因组学到药物遗传学和药物基因组学：过去的经验教训与未来的发展方向。
Drug Metab Rev. 2008;40(2):187-224. doi: 10.1080/03602530801952864.
7
Pharmacogenomics--how close/far are we to practising individualized medicine for children?药物基因组学——我们距离为儿童实施个性化医疗还有多远/近？
Br J Clin Pharmacol. 2015 Mar;79(3):419-28. doi: 10.1111/bcp.12338.
8
Pharmacogenomics: historical perspective and current status.药物基因组学：历史回顾与现状
Methods Mol Biol. 2013;1015:3-22. doi: 10.1007/978-1-62703-435-7_1.
9
Implementation of a multidisciplinary pharmacogenomics clinic in a community health system.在社区卫生系统中实施多学科药物基因组学诊所。
Am J Health Syst Pharm. 2016 Dec 1;73(23):1956-1966. doi: 10.2146/ajhp160072.
10
Pharmacogenomics: bridging the gap between science and practice.药物基因组学：弥合科学与实践之间的差距。
J Am Pharm Assoc (2003). 2010 Jan-Feb;50(1):e1-14; quiz e15-7. doi: 10.1331/JAPhA.2010.09124.
引用本文的文献
1
Key informant perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care in Ontario, Canada: a qualitative description study.加拿大安大略省基层医疗中抗抑郁药物处方的药物基因组学（PGx）检测的关键信息提供者观点：一项定性描述研究
BMJ Open. 2025 Aug 27;15(8):e091562. doi: 10.1136/bmjopen-2024-091562.
2
Pharmacogenomic testing implementation: Tertiary care center experience and results of a pilot of 512 patients.药物基因组学检测的实施：三级医疗中心的经验及512例患者的试点结果。
Genet Med Open. 2025 Mar 22;3:103426. doi: 10.1016/j.gimo.2025.103426. eCollection 2025.
3
Catalyzing Pharmacogenomic Analysis for Informing Pain Treatment (C-PAIN): A Randomized Trial of Preemptive Genotyping in Cancer Palliative Care.催化药物基因组学分析以指导疼痛治疗（C-PAIN）：癌症姑息治疗中抢先基因分型的随机试验。
J Pain Res. 2024 Dec 17;17:4187-4196. doi: 10.2147/JPR.S488416. eCollection 2024.
4
Receptor Pharmacogenomics: Deciphering Genetic Influence on Drug Response.受体药理学基因组学：解析遗传对药物反应的影响。
Int J Mol Sci. 2024 Aug 29;25(17):9371. doi: 10.3390/ijms25179371.
5
Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned.制定一个综合性的药物基因组学采用计划，在学术医疗中心：实际考虑和经验教训。
Clin Pharmacol Ther. 2024 Oct;116(4):914-931. doi: 10.1002/cpt.3402. Epub 2024 Aug 21.
6
Implementation of a pharmacogenetic panel-based test for pharmacotherapy-based supportive care in an adult oncology clinic.在成人肿瘤诊所实施基于药物遗传学panel 的药物治疗支持性护理测试。
Clin Transl Sci. 2024 Jul;17(7):e13890. doi: 10.1111/cts.13890.
7
Forging the path to precision medicine in Qatar: a public health perspective on pharmacogenomics initiatives.在卡塔尔开创精准医学之路：从公共卫生角度看药物基因组学计划。
Front Public Health. 2024 Mar 14;12:1364221. doi: 10.3389/fpubh.2024.1364221. eCollection 2024.
8
Moving towards the implementation of pharmacogenetic testing in Quebec.迈向魁北克药物遗传学检测的实施。
Front Genet. 2024 Jan 3;14:1295963. doi: 10.3389/fgene.2023.1295963. eCollection 2023.
9
Implementation of pre-emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?临床实践中药基因组学检测预测试验的实施：我们目前的进展如何？
Br J Clin Pharmacol. 2025 Feb;91(2):270-282. doi: 10.1111/bcp.15956. Epub 2023 Dec 21.
10
Identification of Drugs Acting as Perpetrators in Common Drug Interactions in a Cohort of Geriatric Patients from Southern Italy and Analysis of the Gene Polymorphisms That Affect Their Interacting Potential.意大利南部老年患者队列中常见药物相互作用中作为肇事者的药物鉴定以及影响其相互作用潜力的基因多态性分析。
Geriatrics (Basel). 2023 Aug 24;8(5):84. doi: 10.3390/geriatrics8050084.
本文引用的文献
1
Company profile: Sequenom, Inc.公司简介：Sequenom, Inc.
Pharmacogenomics. 2012 Apr;13(5):529-31. doi: 10.2217/pgs.12.8.
2
Pharmacogenomics: "noninferiority" is sufficient for initial implementation.药物基因组学：“非劣效性”足以进行初步实施。
Clin Pharmacol Ther. 2011 Mar;89(3):348-50. doi: 10.1038/clpt.2010.310.
3
Personalized medicine: building the GPS to take us there.个性化医疗：构建引领我们抵达目标的全球定位系统。
Clin Pharmacol Ther. 2007 Mar;81(3):321-2. doi: 10.1038/sj.clpt.6100092.
4
Changing physicians' practices.改变医生的诊疗方式。
N Engl J Med. 1993 Oct 21;329(17):1271-3. doi: 10.1056/NEJM199310213291714.
Zotero 插件